Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
20 mei 2008 - 07:31
Statutaire naam
Crucell N.V.
Titel
Crucell Announces Research License Agreement with Bioceros on STAR® Technology
Bericht
Leiden, The Netherlands, 20 May 2008 – Dutch biopharma company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) today announced a non-exclusive STAR® research license agreement with Bioceros. The license agreement with the Netherlands based company Bioceros covers the production of monoclonal antibodies. Financial details of the agreement were not disclosed.
Gerelateerde downloads
Datum laatste update: 22 december 2025